{
  "title": "Atul Gawande and Siddhartha Mukherjee on the State of the Pandemic",
  "link": "http://www.wnyc.org/story/atul-gawande-and-siddhartha-mukherjee-state-pandemic-pm/",
  "description": "<p><span>After a year of battling COVID-19, parts of the United States are celebrating a gradual turn toward normalcy, but the pandemic isn’t over—and it may never be over, exactly.<span> </span></span><a href=\"https://www.newyorker.com/contributors/atul-gawande\"><span>Atul Gawande</span></a><span><span> </span>tells David Remnick that a hard core of vaccine resisters, along with reservoirs of the virus in domestic animals, may make herd immunity elusive. Rather, he says, the correct goal is to bring the impact of COVID-19 down to that of something like the flu. Meanwhile, India is now overwhelmed by a devastating death toll, reported at around four thousand per day but likely much higher. Siddhartha Mukherjee, who<span> </span></span><a href=\"https://www.newyorker.com/magazine/2021/03/01/why-does-the-pandemic-seem-to-be-hitting-some-countries-harder-than-others\"><span>reported</span></a><span><span> </span>on the pandemic in developing nations, says that commitments from the West such as extra doses of the AstraZeneca vaccine will barely scratch the surface. A national mobilization will be required to even begin to flatten the curve.</span></p>",
  "pubDate": "Mon, 10 May 2021 12:00:00 -0400",
  "guid": "083d8785-b394-4cf8-a4b4-a87602bba8ea",
  "enclosure": "",
  "category": [
    "coronavirus",
    "health",
    "india",
    "pandemic",
    "politics",
    "science",
    "vaccine"
  ],
  "media:content": "",
  "media:description": "Atul Gawande and Siddhartha Mukherjee on the State of the Pandemic",
  "media:thumbnail": "",
  "itunes:duration": "18:32",
  "content:encoded": "<p><span>After a year of battling COVID-19, parts of the United States are celebrating a gradual turn toward normalcy, but the pandemic isn’t over—and it may never be over, exactly. </span><a href=\"https://www.newyorker.com/contributors/atul-gawande\"><span>Atul Gawande</span></a><span><span> </span>tells David Remnick that a hard core of vaccine resisters, along with reservoirs of the virus in domestic animals, may make herd immunity elusive. Rather, he says, the correct goal is to bring the impact of COVID-19 down to that of something like the flu. Meanwhile, India is now overwhelmed by a devastating death toll, reported at around four thousand per day but likely much higher. Siddhartha Mukherjee, who<span> </span></span><a href=\"https://www.newyorker.com/magazine/2021/03/01/why-does-the-pandemic-seem-to-be-hitting-some-countries-harder-than-others\"><span>reported</span></a><span><span> </span>on the pandemic in developing nations, says that commitments from the West such as extra doses of the AstraZeneca vaccine will barely scratch the surface. A national mobilization will be required to even begin to flatten the curve.</span></p>",
  "itunes:title": "Atul Gawande and Siddhartha Mukherjee on the State of the Pandemic",
  "itunes:summary": "<p><span>After a year of battling COVID-19, parts of the United States are celebrating a gradual turn toward normalcy, but the pandemic isn’t over—and it may never be over, exactly. </span><a href=\"https://www.newyorker.com/contributors/atul-gawande\"><span>Atul Gawande</span></a><span><span> </span>tells David Remnick that a hard core of vaccine resisters, along with reservoirs of the virus in domestic animals, may make herd immunity elusive. Rather, he says, the correct goal is to bring the impact of COVID-19 down to that of something like the flu. Meanwhile, India is now overwhelmed by a devastating death toll, reported at around four thousand per day but likely much higher. Siddhartha Mukherjee, who<span> </span></span><a href=\"https://www.newyorker.com/magazine/2021/03/01/why-does-the-pandemic-seem-to-be-hitting-some-countries-harder-than-others\"><span>reported</span></a><span><span> </span>on the pandemic in developing nations, says that commitments from the West such as extra doses of the AstraZeneca vaccine will barely scratch the surface. A national mobilization will be required to even begin to flatten the curve.</span></p>",
  "itunes:episodeType": "full",
  "author": "wnycdigital@gmail.com (WNYC Studios and The New Yorker)",
  "itunes:explicit": "no",
  "itunes:subtitle": "After a year of battling COVID-19, parts of the United States are celebrating a gradual turn toward normalcy, but the pandemic isn’t over—and it may never be over, exactly. Atul Gawande tells David Remnick that a hard core of vaccine resisters, along with reservoirs of the virus in domestic animals, may make herd immunity elusive. Rather, he says, the correct goal is to bring the impact of COVID-19 down to that of something like the flu. Meanwhile, India is now overwhelmed by a devastating death toll, reported at around four thousand per day but likely much higher. Siddhartha Mukherjee, who reported on the pandemic in developing nations, says that commitments from the West such as extra doses of the AstraZeneca vaccine will barely scratch the surface. A national mobilization will be required to even begin to flatten the curve.",
  "itunes:author": "WNYC Studios and The New Yorker",
  "itunes:keywords": "President,Obama,Barack,Obama,Washington,Lizza,Wickenden,wnyc"
}